Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D002415:Cats; D002421:Caudate Nucleus / Q000187:drug effects / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects* / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D008032:Limbic System / Q000187:drug effects; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*; D013378:Substantia Nigra / Q000187:drug effects* / Q000378:metabolism; D013997:Time Factors; D014149:Tranquilizing Agents / Q000494:pharmacology*
D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D000661:Amphetamine; D004298:Dopamine